Hood River Capital Management LLC Invests $43,000 in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Hood River Capital Management LLC acquired a new position in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 950 shares of the company’s stock, valued at approximately $43,000.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Nkcfo LLC purchased a new stake in shares of Establishment Labs during the second quarter worth $227,000. Concurrent Investment Advisors LLC acquired a new position in shares of Establishment Labs during the 1st quarter worth about $263,000. SG Americas Securities LLC acquired a new position in shares of Establishment Labs during the 2nd quarter worth about $303,000. Bay Colony Advisory Group Inc d b a Bay Colony Advisors acquired a new position in shares of Establishment Labs during the 2nd quarter worth about $373,000. Finally, Bayesian Capital Management LP acquired a new position in shares of Establishment Labs during the 1st quarter worth about $631,000. Institutional investors and hedge funds own 72.91% of the company’s stock.

Wall Street Analyst Weigh In

ESTA has been the subject of several research analyst reports. Citigroup boosted their price objective on Establishment Labs from $41.00 to $45.00 and gave the stock a “neutral” rating in a research report on Thursday, August 22nd. JPMorgan Chase & Co. cut their price objective on Establishment Labs from $61.00 to $50.00 and set an “overweight” rating for the company in a research report on Wednesday, August 7th. Mizuho boosted their price objective on Establishment Labs from $65.00 to $70.00 and gave the stock a “buy” rating in a research report on Thursday, June 6th. Finally, Stephens reaffirmed an “overweight” rating and issued a $68.00 price target on shares of Establishment Labs in a report on Wednesday, August 7th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $56.60.

Insider Buying and Selling

In related news, CEO Quiros Juan Jose Chacon sold 3,866 shares of the stock in a transaction that occurred on Monday, July 8th. The stock was sold at an average price of $45.01, for a total transaction of $174,008.66. Following the sale, the chief executive officer now directly owns 215,030 shares in the company, valued at approximately $9,678,500.30. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders have sold a total of 14,346 shares of company stock worth $647,806 in the last three months. Insiders own 11.44% of the company’s stock.

Establishment Labs Trading Down 5.5 %

Establishment Labs stock opened at $40.13 on Tuesday. The business has a 50 day moving average price of $43.51 and a two-hundred day moving average price of $47.53. The company has a quick ratio of 2.91, a current ratio of 4.44 and a debt-to-equity ratio of 4.30. The stock has a market cap of $1.10 billion, a price-to-earnings ratio of -12.78 and a beta of 1.20. Establishment Labs Holdings Inc. has a 12 month low of $16.96 and a 12 month high of $60.12.

Establishment Labs (NASDAQ:ESTA) last released its quarterly earnings data on Tuesday, August 6th. The company reported ($0.62) earnings per share for the quarter, missing the consensus estimate of ($0.51) by ($0.11). Establishment Labs had a negative net margin of 54.97% and a negative return on equity of 220.67%. The company had revenue of $44.12 million during the quarter, compared to the consensus estimate of $43.10 million. During the same quarter in the prior year, the company posted ($0.65) earnings per share. The company’s revenue for the quarter was down 9.2% on a year-over-year basis. As a group, equities analysts forecast that Establishment Labs Holdings Inc. will post -2.2 EPS for the current year.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.